CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 31 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-07 | Gordon Stephen Chief Financial Officer | Exercise or conversion | +10,000 | $0.67 | $7K | 15,714 |
| 2021-09-07 | Gordon Stephen Chief Financial Officer | Sale | −10,000 | $35.00 | $350K | 5,714 |
| 2021-09-07 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2021-09-01 | Carey John F VP of Operations | Exercise or conversion | +1,680 | $2.21 | $4K | 1,680 |
| 2021-09-01 | Carey John F VP of Operations | Sale | −1,080 | $31.77 | $34K | 600 |
| 2021-09-01 | Carey John F VP of Operations | Sale | −600 | $32.37 | $19K | 0 |
| 2021-09-01 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,680 | 15,633 | ||
| 2021-08-30 | Sullivan John F VP of Quality & Engineering | Exercise or conversion | +3,200 | $0.28 | $896 | 14,273 |
| 2021-08-30 | Sullivan John F VP of Quality & Engineering | Exercise or conversion · Stock Option (Right to Buy) | −3,200 | 15,772 | ||
| 2021-08-04 | Godhani Rakesh P. Chief Digital Officer | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2021-08-02 | Carey John F VP of Operations | Exercise or conversion | +1,680 | $2.21 | $4K | 1,680 |
| 2021-08-02 | Carey John F VP of Operations | Sale | −1,680 | $28.33 | $48K | 0 |
| 2021-08-02 | Carey John F VP of Operations | Exercise or conversion · Stock Option (Right to Buy) | −1,680 | 17,313 | ||
| 2021-07-30 | Provost Miriam VP of US Regulatory & FDA Rel. | Exercise or conversion | +2,206 | $3.22 | $7K | 6,806 |
| 2021-07-30 | Provost Miriam VP of US Regulatory & FDA Rel. | Exercise or conversion · Stock Option (Right to Buy) | −2,206 | 21,765 | ||
| 2021-07-15 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +5,152 | $0.28 | $1K | 51,228 |
| 2021-07-15 | Khayal Tamer I Chief Commercial Officer | Sale | −5,152 | $35.10 | $181K | 46,076 |
| 2021-07-15 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,152 | 23,126 | ||
| 2021-07-15 | Gordon Stephen Chief Financial Officer | Exercise or conversion | +10,000 | $0.67 | $7K | 15,714 |
| 2021-07-15 | Gordon Stephen Chief Financial Officer | Sale | −10,000 | $35.00 | $350K | 5,714 |
Page 42 of 49 · 980 trades